Chikungunya Vaccine Trends and Forecast
The future of the global chikungunya vaccine market looks promising with opportunities in the hospital pharmacy and retail pharmacy markets. The global chikungunya vaccine market is expected to reach an estimated $0.5 billion by 2030 with a CAGR of 9.7% from 2024 to 2030. The major drivers for this market are rising awareness of infections transmitted by mosquitoes, expanding government programs for chikungunya prevention and control, and increasing chikungunya fever prevalence.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Chikungunya Vaccine by Segment
The study includes a forecast for the global chikungunya vaccine by type, age group, end use, and region.
Chikungunya Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Live-Attenuated Virus Vaccines
• Inactivated Viral Vaccines
• Chimeric-Alphavirus Candidates
• Recombinant Viral Vaccines
• Others
Chikungunya Vaccine Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:
• Paediatric
• Adult
• Geriatric
Chikungunya Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Pharmacies
• Retail Pharmacies
• Others
Chikungunya Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Chikungunya Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chikungunya vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chikungunya vaccine companies profiled in this report include-
• Takeda Pharmaceutical Company
• Valneva
• Moderna
• Emergent BioSolutions
• Bharat Biotech
Chikungunya Vaccine Market Insights
Lucintel forecasts that live-attenuated is expected to witness the highest growth over the forecast period.
Within this market, hospital pharmacy is expected to witness the higher growth.
North America is expected to witness highest growth over the forecast period.
Features of the Global Chikungunya Vaccine Market
Market Size Estimates: Chikungunya vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Chikungunya vaccine market size by type, age group, end use, and region in terms of value ($B).
Regional Analysis: Chikungunya vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, age groups, end uses, and regions for the chikungunya vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chikungunya vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the chikungunya vaccine market size?
Answer: The global chikungunya vaccine market is expected to reach an estimated $0.5 billion by 2030.
Q2. What is the growth forecast for chikungunya vaccine market?
Answer: The global chikungunya vaccine market is expected to grow with a CAGR of 9.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the chikungunya vaccine market?
Answer: The major drivers for this market are rising awareness of infections transmitted by mosquitoes, expanding government programs for chikungunya prevention and control, and increasing chikungunya fever prevalence.
Q4. What are the major segments for chikungunya vaccine market?
Answer: The future of the chikungunya vaccine market looks promising with opportunities in the hospital pharmacy and retail pharmacy markets.
Q5. Who are the key chikungunya vaccine market companies?
Answer: Some of the key chikungunya vaccine companies are as follows:
• Takeda Pharmaceutical Company
• Valneva
• Moderna
• Emergent BioSolutions
• Bharat Biotech
Q6. Which chikungunya vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that live-attenuated is expected to witness the highest growth over the forecast period.
Q7. In chikungunya vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the chikungunya vaccine market by type (live-attenuated virus vaccines, inactivated viral vaccines, chimeric-alphavirus candidates, recombinant viral vaccines, and others), age group (paediatric, adult, and geriatric), end use (hospital pharmacies, retail pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Chikungunya Vaccine Market, Chikungunya Vaccine Market Size, Chikungunya Vaccine Market Growth, Chikungunya Vaccine Market Analysis, Chikungunya Vaccine Market Report, Chikungunya Vaccine Market Share, Chikungunya Vaccine Market Trends, Chikungunya Vaccine Market Forecast, Chikungunya Vaccine Companies, write Lucintel analyst at email:Â helpdesk@lucintel.com. We will be glad to get back to you soon.